Chandra Bhagat Pharma Ltd.

BSE: 542934|

Chandra Bhagat Pharma Live Share Price Today, Share Analysis and Chart

Name: Chandra Bhagat Pharma Ltd.: Is Infosys Ltd. worth buying?
Item: Chandra Bhagat Pharma Ltd.
Rating: 2.56075
Author: Trendlyne DVM scores

aboutChandra Bhagat Pharma Ltd. is an Indian pharmaceutical company primarily engaged in the marketing, distribution, and export of a diverse range of pharmaceutical formulations. The company focuses on therapeutic segments such as **oncology, critical ca... Read More

2.59(4.99%)

New 52W High today

4,000

BSE Volume

BSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

60.9 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

10Positive6Negative

Pass in checklist62.5%

045

100

Check P/E Buy Sell Zone

Strong Buy Zone

12.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Chandra Bhagat Pharma Stock Price Analysis

Day Price Range 5.0% 1 Day return	54.5 (LTP) 54.554.5 LowHigh
Week Price Range 39.7% 1 Week return	54.5 (LTP) 42.954.5 LowHigh
Month Price Range 10.3% 1 Month return	54.5 (LTP) 3554.5 LowHigh
52 Week Price Range 32.5% 1 Year return	54.5 (LTP) 29.754.5 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Chandra Bhagat Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Chandra Bhagat Pharma Mar-2026 Annual Revenue is Rs 120 Cr which is growth of 29.7% YoY.
POSITIVE
Annual Net Profit Chandra Bhagat Pharma Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 255.1% YoY.

Chandra Bhagat Pharma Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
SR_A Total Rev. Ann. ⌄	-0.1%	10.9%	119.6	92.2	232.7	120	95.7	71.2	94.4	106.7	97.7	90.3
TotalOperatingRevenues_A Operating Rev. Ann.	-1%	10.5%	116.3	88.8	221.4	119.7	94.1	70.7	94	106.3	97.1	89.8
OI_A Other Income Ann.	124.6%	46.7%	3.4	3.4	11.3	0.3	1.6	0.5	0.4	0.4	0.7	0.5
OEXPNS_A Operating Exp. Ann.	-1.2%	9.8%	112.4	88.1	228.4	116.4	91.4	70.4	90.9	102	93	85.9
OEXPNS_A Operating Exp. Ann.	-1.2%	9.8%	112.4	88.1	228.4	116.4	91.4	70.4	90.9	102	93	85.9
OP_A Operating Profit Ann.	5.7%	67%	3.9	0.7	-7	3.3	2.7	0.3	3.1	4.2	4.1	3.9
OPMPCT_A OPM Ann. %	5.1%	48.2%	3.22%	0.72%	-3.03%	2.77%	2.80%	0.45%	3.25%	3.97%	4.17%	4.32%
TotalExpenses_A Total Exp. Ann. ⌄	-0.9%	10.3%	115.5	91	230.4	118.8	94.6	70.9	94	105.8	96.2	89.4
OtherExpenses_A Other Exp. Ann.	24.7%	13.1%	15.9	12.4	17.7	8.2	8.3	8.6	2.7	5	5.4	6.5
EmployeeBenefitExpenses_A Employee Exp. Ann.	23.3%	8.4%	3	2.5	2.7	1.6	1.7	2	2.4	4.7	5.2	5.8
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	26%	55.2%	7.2	4.1	4.3	3.6	4.3	0.8	3.5	4.7	4.8	4.4
EBIDTPCT_A EBITDA Ann. margin %	26%	40%	6.02%	4.41%	1.84%	3.01%	4.49%	1.12%	3.72%	4.38%	4.86%	4.87%
INT_A Interest Ann.	-3.1%	32%	2	2	1.4	2.2	3.1	0.5	3.1	3.7	3.2	3.3
DEP_A Depr.	54.2%	-	1.1	1	0.6	0.3	0.1	0	0	0.1	0.1	0.1
PBT_A PBT Ann.	50.6%	68.7%	4.1	1.2	2.3	1.2	1.1	0.3	0.4	0.9	1.5	0.9
TAX_A Tax Ann.	54.2%	61.5%	1.1	0.3	0.7	0.3	0.3	0.1	0.1	0.3	0.5	0.3
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	51%	73%	3.1	0.9	1.5	0.9	0.8	0.2	0.3	0.6	1	0.7
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	51%	73%	3.1	0.9	1.5	0.9	0.8	0.2	0.3	0.6	1	0.7
NETPCT_A NPM Ann. %	51.5%	58.6%	2.61%	0.96%	0.69%	0.75%	0.84%	0.26%	0.33%	0.58%	1.06%	0.73%
EPS_adj_A EPS Adj. latest Ann.	49.4%	67.9%	4	1.1	2	1.2	1.1	0.3	0.4	0.8	1.4	0.9
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

29.7%

2Y CAGR

-28.3%

3Y CAGR

-0.1%

5Y CAGR

10.9%

7Y CAGR

1.6%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

244.4%

2Y CAGR

43.8%

3Y CAGR

51%

5Y CAGR

73%

7Y CAGR

26.4%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

27.6%

2Y CAGR

-29.8%

3Y CAGR

-1.2%

5Y CAGR

9.8%

7Y CAGR

1.4%

Operating Expenses Annual Cr growth is higher than historical averages.

Chandra Bhagat Pharma Technical Analysis

Chandra Bhagat Pharma EMA & SMA

Bullish+8

8 bullish, 0 bearish

Bullish8

Bearish0

5 Day	49.1
10 Day	46.6
12 Day	46.2
20 Day	45.4

26 Day	45.0
50 Day	43.6
100 Day	44.0
200 Day	51.2

Chandra Bhagat Pharma Delivery And Volume

Daily Avg. Delivery Volume %

30 Oct, 2026100.0%

Week100.0%

Month-

Chandra Bhagat Pharma Active Candlesticks

Short Line Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Chandra Bhagat Pharma Resistance and Support

54.48

Pivot

First Resistance	54.5
Second Resistance	54.5
Third Resistance	54.5

First Support	54.5
Second Support	54.5
Third Support	54.5

Day RSI	66.4
Day MACD	1.3
Day MFI	28.4
Day MACD Signal Line	0.4

Chandra Bhagat Pharma Beta

1 Month	-1.2
1 Year	-0.2

3 Month	-0.6
3 Year	-0.1

Chandra Bhagat Pharma Price Change Analysis

↑10.3%

Over 1 Month

LowHigh

35.054.5

↑43.7%

Over 3 Months

LowHigh

35.054.5

↑65.1%

Over 6 Months

LowHigh

29.754.5

↑32.5%

Over 1 Year

LowHigh

29.754.5

Chandra Bhagat Pharma Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Hemant Chandravadan Bhagat	Promoter	2,678,296	35.5 %
Team Anamika Algo Limited	Public	435,000	5.8 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Chandra Bhagat Pharma Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
BENGAL TIGER CAPITAL ADVISORS LLP	Bulk	Sell	08 Oct 2026	41.75	60,000	BSE
ROHIT BHAILAL SHAH	Bulk	Purchase	08 Oct 2026	42	42,000	BSE
TEAM ANAMIKA ALGO LIMITED	Bulk	Sell	16 Jun 2026	44	49,000	BSE
BENGAL TIGER CAPITAL ADVISORS LLP	Bulk	Purchase	22 May 2026	39.90	62,000	BSE
TEAM ANAMIKA ALGO LIMITED	Bulk	Sell	22 May 2026	39.93	60,000	BSE
PRACHI PRANAV BHAGAT	Bulk	Purchase	27 Feb 2026	39.89	62,000	BSE
PRACHI PRANAV BHAGAT	Bulk	Purchase	28 Jul 2025	53.84	39,000	BSE
M7 GLOBAL FUND PCC - NOLANA	Bulk	Purchase	19 Feb 2025	64.61	46,000	BSE
PRACHI PRANAV BHAGAT	Bulk	Purchase	28 Nov 2024	68.84	64,000	BSE
PIYUSH SECURITIES PVT LTD	Bulk	Sell	28 Nov 2024	68.84	63,000	BSE

All deals

All insider trades

Chandra Bhagat Pharma Corporate Actions

Chandra Bhagat Pharma Board Meetings

Chandra Bhagat Pharma past and upcoming board meetings.

#Ex-Date	Purpose	Notes
105 Aug 2026	Fund raising through preferential issue	-
225 May 2026	Audited Results	-
313 Nov 2025	Half Yearly Results	-
429 May 2025	Audited Results	-
513 Nov 2024	Half Yearly Results	-

All Corporate Actions

Chandra Bhagat Pharma Corporate Filings

Chandra Bhagat Pharma BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Date	Announcement Title	Details	Links
27 Oct 2026	Chandra Bhagat Pharma Ltd - 542934 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Ramkant Dave	PDF
27 Oct 2026	Chandra Bhagat Pharma Ltd - 542934 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chintan Vijay Makhecha	PDF
26 Oct 2026	Chandra Bhagat Pharma Ltd - 542934 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Chandravadan Bhagat & PACs	PDF
22 Oct 2026	Chandra Bhagat Pharma Ltd - 542934 - Announcement under Regulation 30 (LODR)-Allotment	Please find attached disclosure under Reg 30 of SEBI (LODR) Regulations, 2015 for your reference.	PDF
22 Oct 2026	Chandra Bhagat Pharma Ltd - 542934 - Announcement under Regulation 30 (LODR)-Allotment	Please find attached disclosure under Reg 30 of SEBI (LODR) Regulations, 2015 for your reference.	PDF

VIEW ALL

Chandra Bhagat Pharma DocumentsAsk MarketMind AI

Chandra Bhagat Pharma Annual Reports

Chandra Bhagat Pharma financials, including annual results, balance sheets, and cash flow statements.

Date	Report Title	Links
2020	Annual Report Mar-2020	Link

Chandra Bhagat Pharma - Company Profile

Chandra Bhagat Pharma Management Structure

Chandra Bhagat Pharma management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Prachi Pranav Bhagat	Executive Director,Whole Time Director	12.07	Mar 26
Rajni Dawani	Company Secretary,Compliance Officer	-	Mar 26

Chandra Bhagat Pharma Board of Directors

Chandra Bhagat Pharma Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Hemant C Bhagat	Chairman / Executive Director / M D / Promoter	24	Mar 26
Pranav H Bhagat	WTD & Executive Director	24	Mar 26
Prachi Pranav Bhagat	Executive Director & CFO	12.07	Mar 26
Ravindra Gajanan Awati	Independent Non Exe. Director	-	Mar 26
Abha Praveen Doshi	Independent Non Exe. Director	-	Mar 26
Rajni Dawani	Company Sec. & Compli. Officer	-	Mar 26

About

Website: www.cbcpharma.com

About the company - Business Profile

Chandra Bhagat Pharma Ltd. is an Indian pharmaceutical company primarily engaged in the marketing, distribution, and export of a diverse range of pharmaceutical formulations. The company focuses on therapeutic segments such as oncology, critical care, and life-saving drugs. Operating within the SME segment, it serves both domestic and international markets, specializing in the procurement and supply of specialized medicinal products.

Key Points

Key Facts: The company is headquartered in Mumbai, Maharashtra, and was incorporated as a public limited company. It is listed on the BSE SME platform.
Operations and Business Model: Chandra Bhagat Pharma operates on an asset-light business model, primarily focusing on the distribution and marketing of generic formulations and specialized pharmaceutical products. It leverages a network of third-party manufacturers and distribution partners to reach its target markets.
Market and Significance: The company occupies a niche in the high-stakes therapeutic areas of oncology and critical care. Its strategic importance lies in its ability to manage the supply chain for critical medications, including injections and specialized tablets, for hospital networks and international clients.
Financial Performance (FY2024-25):
- Revenue from Operations: Total revenue for the fiscal year ended March 31, 2025, stood at ₹8,671.61 lakhs.
- Profitability: The company reported a Profit After Tax (PAT) of ₹85.78 lakhs for FY2024-25.
- Expenses: The total expenditure for FY2024-25 was ₹9,107.37 lakhs, with the purchase of stock-in-trade being the largest cost component at ₹6,529.65 lakhs.
- Employee Benefits: Employee-related expenses for the full year 2024-25 amounted to ₹256.88 lakhs.
Current Financial Position (As of September 30, 2025):
- Total Assets: ₹8,820.10 lakhs.
- Shareholders' Funds: ₹3,041.82 lakhs, comprising a Share Capital of ₹754.51 lakhs and Reserves & Surplus of ₹2,287.31 lakhs.
- Liquidity: Cash and bank balances were reported at ₹138.25 lakhs.
Strategic Initiatives and Outlook: The company is focused on expanding its product portfolio within the critical care segment and strengthening its presence in international emerging markets. Current initiatives include optimizing the working capital cycle and managing short-term borrowings, which stood at ₹2,004.25 lakhs as of September 2025.

References

Result Nov 2025

Chandra Bhagat Pharma FAQ

Chandra Bhagat Pharma today is trading in the green, up by 4.99% at ₹54.48.

Chandra Bhagat Pharma is currently trading up 4.99% on an intraday basis. In the past week the stock rose 39.69%. Stock has been up 43.67% in the past quarter and rose 32.49% in the past year. You can view this in the share price history/seasonality section.

Chandra Bhagat Pharma is listed on BSE with ticker 542934. It's currently trading on BSE at a share price of ₹54.48.

The market cap of Chandra Bhagat Pharma is ₹41.11 Cr. as of Oct 30, 2026.

Chandra Bhagat Pharma has never announced any dividend since the time of its listing on the BSE exchange.

Chandra Bhagat Pharma has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

Chandra Bhagat Pharma reported ₹119.63 Cr. in revenue, ₹3.05 Cr. in net profit, and ₹7.21 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Chandra Bhagat Pharma.

The PE ratio of Chandra Bhagat Pharma is 13.49 as of Oct 30, 2026.

The PB ratio of Chandra Bhagat Pharma is 1.24 as of Oct 30, 2026.

There are no analyst reports for Chandra Bhagat Pharma.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Chandra Bhagat Pharma Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Chandra Bhagat Pharma Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Chandra Bhagat Pharma - Annual

Chandra Bhagat Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Chandra Bhagat Pharma Mar-2026 Annual Revenue is Rs 120 Cr which is growth of 29.7% YoY.

Annual Net Profit Chandra Bhagat Pharma Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 255.1% YoY.

Chandra Bhagat Pharma Technical Analysis

Chandra Bhagat Pharma EMA & SMA

Chandra Bhagat Pharma Delivery And Volume

Chandra Bhagat Pharma Active Candlesticks

Chandra Bhagat Pharma Resistance and Support

Chandra Bhagat Pharma Beta

Chandra Bhagat Pharma Price Change Analysis

Chandra Bhagat Pharma Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Chandra Bhagat Pharma Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Chandra Bhagat Pharma Corporate Actions

Chandra Bhagat Pharma Board Meetings

Chandra Bhagat Pharma past and upcoming board meetings.

Chandra Bhagat Pharma Corporate Filings

Chandra Bhagat Pharma BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Chandra Bhagat Pharma DocumentsAsk MarketMind AI

Chandra Bhagat Pharma Annual Reports

Chandra Bhagat Pharma financials, including annual results, balance sheets, and cash flow statements.

Chandra Bhagat Pharma - Company Profile

Chandra Bhagat Pharma Management Structure

Chandra Bhagat Pharma management structure with salaries, total experience, and qualifications.

Chandra Bhagat Pharma Board of Directors

Chandra Bhagat Pharma Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

Chandra Bhagat Pharma FAQ

How is Chandra Bhagat Pharma today?

Chandra Bhagat Pharma today is trading in the green, up by 4.99% at ₹54.48.

How has Chandra Bhagat Pharma performed historically?

Chandra Bhagat Pharma is currently trading up 4.99% on an intraday basis. In the past week the stock rose 39.69%. Stock has been up 43.67% in the past quarter and rose 32.49% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Chandra Bhagat Pharma on NSE and BSE exchanges?

Chandra Bhagat Pharma is listed on BSE with ticker 542934. It's currently trading on BSE at a share price of ₹54.48.

What is the market cap of Chandra Bhagat Pharma?

The market cap of Chandra Bhagat Pharma is ₹41.11 Cr. as of Oct 30, 2026.

When did Chandra Bhagat Pharma last pay a dividend, and what has its dividend history been?

Chandra Bhagat Pharma has never announced any dividend since the time of its listing on the BSE exchange.

Has Chandra Bhagat Pharma issued any bonus shares or share splits recently?

Chandra Bhagat Pharma has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

What do the financial statements and annual reports of Chandra Bhagat Pharma Indicate?

Chandra Bhagat Pharma reported ₹119.63 Cr. in revenue, ₹3.05 Cr. in net profit, and ₹7.21 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Chandra Bhagat Pharma according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Chandra Bhagat Pharma.

What is the PE Ratio of Chandra Bhagat Pharma?

The PE ratio of Chandra Bhagat Pharma is 13.49 as of Oct 30, 2026.

What is the PB Ratio of Chandra Bhagat Pharma?

The PB ratio of Chandra Bhagat Pharma is 1.24 as of Oct 30, 2026.

Where can I check the latest Research Reports about Chandra Bhagat Pharma?

There are no analyst reports for Chandra Bhagat Pharma.

How can I be notified of real time alerts about Chandra Bhagat Pharma stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.